Tempus AI (NASDAQ:TEM) Trading Up 1.3% – Still a Buy?

Tempus AI, Inc. (NASDAQ:TEM) was up 1.3% on Monday . The company traded as high as $47.88 and last traded at $47.80. Approximately 3,700,512 shares traded hands during mid-day trading, a decline of 25% from the average daily volume of 4,927,286 shares. The stock had previously closed at $47.17.

Wall Street Analyst Weigh In

TEM has been the subject of several recent research reports. Needham & Company LLC boosted their price target on Tempus AI from $56.00 to $70.00 and gave the company a “buy” rating in a research note on Tuesday, February 25th. Bank of America upped their price objective on shares of Tempus AI from $54.00 to $60.00 and gave the stock a “neutral” rating in a report on Monday, March 3rd. William Blair reissued a “market perform” rating on shares of Tempus AI in a research report on Tuesday, February 25th. TD Cowen reiterated a “buy” rating and set a $74.00 target price (up from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Finally, Morgan Stanley raised their price objective on Tempus AI from $50.00 to $60.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $61.18.

Tempus AI Stock Up 5.4 %

The stock’s 50 day simple moving average is $55.33 and its two-hundred day simple moving average is $51.65. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

Insider Buying and Selling

In other Tempus AI news, major shareholder Bradley A. Keywell sold 170,720 shares of the company’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $35.45, for a total transaction of $6,052,024.00. Following the completion of the sale, the insider now owns 15,993,729 shares in the company, valued at approximately $566,977,693.05. The trade was a 1.06 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO Ryan M. Bartolucci sold 13,770 shares of the business’s stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $60.00, for a total value of $826,200.00. Following the transaction, the chief accounting officer now owns 57,237 shares of the company’s stock, valued at $3,434,220. The trade was a 19.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,749,469 shares of company stock worth $322,529,733 in the last quarter.

Institutional Investors Weigh In On Tempus AI

Large investors have recently made changes to their positions in the stock. ARK Investment Management LLC increased its position in shares of Tempus AI by 132.1% in the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock valued at $186,343,000 after acquiring an additional 3,141,487 shares during the last quarter. NEA Management Company LLC increased its position in shares of Tempus AI by 17.8% during the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock worth $304,846,000 after purchasing an additional 813,169 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Tempus AI by 166.0% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after purchasing an additional 2,021,394 shares in the last quarter. Nikko Asset Management Americas Inc. boosted its holdings in shares of Tempus AI by 166.0% in the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after buying an additional 2,021,394 shares during the last quarter. Finally, Franklin Resources Inc. grew its stake in shares of Tempus AI by 240.5% in the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock valued at $93,251,000 after buying an additional 1,950,862 shares in the last quarter. Institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.